{"changes":[],"country":"IT","description":"BetaGlue Therapeutics develops targeted nuclear medicine for solid tumors, led by YntraDose, an Yttrium-90 microsphere radiotherapy delivered directly into the tumor. It serves cancer patients with hard-to-treat solid tumors such as locally advanced pancreatic cancer and hepatocellular carcinoma. Its interventional approach concentrates radiation inside the tumor to spare healthy tissue compared with external-beam radiotherapy.","domain":"betaglue.com","employees":null,"founded":2009,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotech","investors":[],"lat":45.475604,"lng":9.195211,"location":"Milan, Italy","name":"Betaglue Technologies","rounds":[{"amountQuarantined":false,"amountUsd":2700000,"currency":"EUR","date":"2024-04-01","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-02","status":"attributed","url":null},"status":"attributed","type":"grant","url":null}],"slug":"betaglue-com","sources":[{"fact":"round","publisher":"eu-grant","retrievedAt":"2026-05-02","status":"attributed","url":null},{"fact":"existence","publisher":"betaglue.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://betaglue.com"},{"fact":"description","publisher":"betaglue.com","retrievedAt":"2026-05-02","status":"self-reported","url":"https://betaglue.com"}],"stage":null,"techStack":["WordPress 7.0","Yoast SEO 27.4","reCAPTCHA","jQuery Migrate 3.4.1","PHP","cdnjs","Contact Form 7 6.1.5","Python","Cloudflare","MySQL","jquery 3.7.1"],"totalRaisedUsd":33580000,"updatedAt":"2026-05-02"}